Despite Baotou Dongbao Bio-Tech's slightly low ROE, the comp...
Despite Baotou Dongbao Bio-Tech's slightly low ROE, the company's net income growth and inferred efficient management stand out. Although the ROE is lower, significant future earnings growth is anticipated given the high reinvestment rate.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more